Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
53
# OF OVERLAPPING
HOLDINGS
VHT
411
HOLDINGS
14%
ALSO IN WDNA
WDNA
90
HOLDINGS
63%
ALSO IN VHT
SECTOR DRIFT (VHT minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.9% | 2.7% | 2.7% |
|
GILEAD SCIENCES INC | 2.5% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.8% | 1.7% |
|
AMGEN INC | 2.7% | 1.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 1.5% | 1.5% |
VHT Overweight Relative to WDNA
|
ELI LILLY & CO | 7.2% |
|
ABBVIE INC | 5.4% |
|
UNITEDHEALTH GROUP INC | 4.8% |
|
ABBOTT LABORATORIES | 4.0% |
|
JOHNSON & JOHNSON | 3.8% |
|
INTUITIVE SURGICAL INC | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.7% |
|
MERCK & CO. INC. | 2.6% |
|
STRYKER CORP | 2.3% |
 |
MEDTRONIC PLC | 2.0% |
VHT Underweight Relative to WDNA
|
NATERA INC | -3.3% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERICEL CORPORATION | -2.5% |
|
BRIDGEBIO PHARMA, INC. | -2.3% |
|
VERACYTE INC | -2.0% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
 |
NOVARTIS AG | -1.7% |
|
DUPONT DE NEMOURS INC | -1.5% |